Experience:
2023 -
Medipol Bahçelievler
2017 - 2023
Özel İstinye Üniv. Gaziosmanpaşa Medical Park Hopspital
2015 - 2017
DPÜ Evliya Çelebi Eğitim ve Araştırma Hastanesi
2012 - 2015
Süleyman Demirel Üniversitesi Tıp Fakültesi
2008 - 2011
Kırıkkale Devlet Hastanesi
2007 - 2007
Elazığ Eğitim ve Araştırma Hastanesi
2007 - 2008
Eskişehir Asker Hastanesi
2005 - 2007
Elazığ Karakoçan Devlet Hastanesi
2001 - 2001
Batman Beşiri İkiköprü Sağlık Ocağı
2001 - 2005
Dicle Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı
Education:
2015
Süleyman Demirel University Faculty of Medicine, Nephrology
2005
Dicle University Faculty of Medicine, Internal Medicine
2000
Ege University, Faculty of Medicine
Title: Prospective Surveillance Study For Risk Factors Of Central Venous Catheter-Related Bloodstream Infections.
Title: Serum C-Reactive Protein (CRP) Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovarian Syndrome, And Effect Of Bicalutamide On Hirsutism, CRP Levels And Insulin Resistance.
Title: Spontaneous Rupture Of The Spleen In A Hemodialysis Patient.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Fenofibrate Treatment In Two Adults With Crigler-Najjar Syndrome Type II.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
Title: The Relationship Between Serum C-Reactive Protein Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovary Syndrome.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
Experience:
2023 -
Medipol Bahçelievler
2017 - 2023
Özel İstinye Üniv. Gaziosmanpaşa Medical Park Hopspital
2015 - 2017
DPÜ Evliya Çelebi Eğitim ve Araştırma Hastanesi
2012 - 2015
Süleyman Demirel Üniversitesi Tıp Fakültesi
2008 - 2011
Kırıkkale Devlet Hastanesi
2007 - 2007
Elazığ Eğitim ve Araştırma Hastanesi
2007 - 2008
Eskişehir Asker Hastanesi
2005 - 2007
Elazığ Karakoçan Devlet Hastanesi
2001 - 2001
Batman Beşiri İkiköprü Sağlık Ocağı
2001 - 2005
Dicle Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı
Education:
2015
Süleyman Demirel University Faculty of Medicine, Nephrology
2005
Dicle University Faculty of Medicine, Internal Medicine
2000
Ege University, Faculty of Medicine
Title: Prospective Surveillance Study For Risk Factors Of Central Venous Catheter-Related Bloodstream Infections.
Title: Serum C-Reactive Protein (CRP) Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovarian Syndrome, And Effect Of Bicalutamide On Hirsutism, CRP Levels And Insulin Resistance.
Title: Spontaneous Rupture Of The Spleen In A Hemodialysis Patient.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Fenofibrate Treatment In Two Adults With Crigler-Najjar Syndrome Type II.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
Title: The Relationship Between Serum C-Reactive Protein Levels And Insulin Resistance In Non-Obese Women With Polycystic Ovary Syndrome.
Title: The Effects Of Viral Cirrhosis On Cardiac Ventricular Function.
Title: Multipl Atrial Thrombus Developing in a Splenectomized Thalassemia Major Patient.
Title: Hypochromic Microcytic Anemia Presenting with Thalassemia Minor and Lead Intoxication.
Title: The Effects Of Allopurinol On Metabolic Acidosis And Endothelial Functions In Chronic Kidney Disease Patients.
Title: Vaginal Leakage Of Peritoneal Dialysate In A Peritoneal Dialysis Patient.
Title: The Effect Of Biocompatible Peritoneal Dialysis Solutions On Neutrophil To Lymphocyte Ratio.
Title: Utility Of Serum Creatinine/Cystatin C Ratio In Diagnosis Of Kidney Dysfunction In Type 2 Diabetes Mellitus Patients.
| Cita con el médico | precio a consultar |
| Diálisis | $200 |
| Nefrectomía | $8000 - $12000 |
After receiving his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology, Dr. Della Torre worked for 3 years in the United States at the “Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard Medical School” in Boston. Thanks to a Cariplo Foundation research grant, Dr. Della Torre returned to Italy in 2018 and established his lab within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy).
Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital.
Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and achieved prestigious awards such as the Collegio Ghislieri and the Cariplo Foundation awards for young researchers, the TRIDEO award, the MyFirst AIRC research grant, and the Career Research Grant Award from the FOREUM Foundation.
With his seminal works Dr. Della Torre contributed to the characterization of a novel autoimmune disease known as “IgG4-related disease” and is currently considered “World Expert of IgG4-related disease” by the prestigious Expertscape platform.
Dr. Della Torre is the Disease Coordinator of the IgG4-related disease European working group of the European Reference Network (ERN) on Rare Connective Tissue and Musculoskeletal Diseases (ReCONNET).
Up to September 2022, his scientific publications received more than 6000 citations with an H-index of 35.
Dr. Della Torre presented his studies in different national and international immune-rheumatologic congresses, organized a number of scientific meetings, and co-authored 10 medical books. He presently serves as reviewer for more than 50 peer-reviewed journals and as associated editor for three international scientific journals. Dr. Della Torre is a Head of the:
After receiving his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology, Dr. Della Torre worked for 3 years in the United States at the “Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard Medical School” in Boston. Thanks to a Cariplo Foundation research grant, Dr. Della Torre returned to Italy in 2018 and established his lab within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy).
Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital.
Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and achieved prestigious awards such as the Collegio Ghislieri and the Cariplo Foundation awards for young researchers, the TRIDEO award, the MyFirst AIRC research grant, and the Career Research Grant Award from the FOREUM Foundation.
With his seminal works Dr. Della Torre contributed to the characterization of a novel autoimmune disease known as “IgG4-related disease” and is currently considered “World Expert of IgG4-related disease” by the prestigious Expertscape platform.
Dr. Della Torre is the Disease Coordinator of the IgG4-related disease European working group of the European Reference Network (ERN) on Rare Connective Tissue and Musculoskeletal Diseases (ReCONNET).
Up to September 2022, his scientific publications received more than 6000 citations with an H-index of 35.
Dr. Della Torre presented his studies in different national and international immune-rheumatologic congresses, organized a number of scientific meetings, and co-authored 10 medical books. He presently serves as reviewer for more than 50 peer-reviewed journals and as associated editor for three international scientific journals. Dr. Della Torre is a Head of the:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Nefrólogo, especialista en trasplante renal
Mostrar másNefrólogo, especialista en trasplante renal
El Dr. Chetan Prakash es un cirujano ortopédico especialista con calificaciones MBBS, D-Ortho y DNB (Ortho). Tiene una amplia experiencia en reemplazos de cadera y rodilla, cirugía de revisión, restauración de cadera y otras cirugías ortopédicas. Ha completado una beca en cirugía ortopédica y traumatología deportiva del Kanto Hospital Bruderholz en Basilea, Suiza. El Dr. Prakash habla inglés, árabe e hindi, y tiene un interés especial en las lesiones deportivas, el fijador externo Ilizarov, los clavos entrelazados y la artroplastia de cadera y rodilla. Ha publicado su tesis de investigación sobre alargamiento de extremidades en revistas internacionales.
Mostrar másEl Dr. Chetan Prakash es un cirujano ortopédico especialista con calificaciones MBBS, D-Ortho y DNB (Ortho). Tiene una amplia experiencia en reemplazos de cadera y rodilla, cirugía de revisión, restauración de cadera y otras cirugías ortopédicas. Ha completado una beca en cirugía ortopédica y traumatología deportiva del Kanto Hospital Bruderholz en Basilea, Suiza. El Dr. Prakash habla inglés, árabe e hindi, y tiene un interés especial en las lesiones deportivas, el fijador externo Ilizarov, los clavos entrelazados y la artroplastia de cadera y rodilla. Ha publicado su tesis de investigación sobre alargamiento de extremidades en revistas internacionales.